来自新冠病毒阳性供体的异基因造血干细胞移植。 - Suppr

Suppr

超能文献

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors.

作者信息

Leclerc Mathieu, Fourati Slim, Menouche Dehbia, Challine Dominique, Maury Sébastien

机构信息

Department of Hematology, Department of Virology, Hopital Henri Mondor, Créteil, Paris 94000, France.

出版信息

Lancet Haematol. 2021 Mar;8(3):e167-e169. doi: 10.1016/S2352-3026(21)00025-9. Epub 2021 Feb 1.

DOI:10.1016/S2352-3026(21)00025-9

PMID:33539769

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7906696/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6021/7906696/f6b7ffbb330b/fx1_lrg.jpg

相似文献

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors.来自新冠病毒阳性供体的异基因造血干细胞移植。

Lancet Haematol. 2021 Mar;8(3):e167-e169. doi: 10.1016/S2352-3026(21)00025-9. Epub 2021 Feb 1.

The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact.英国国家卫生与临床优化研究所（NICE）关于造血干细胞移植的新冠肺炎快速指南：制定、实施与影响

Br J Haematol. 2021 Feb;192(3):467-473. doi: 10.1111/bjh.17280. Epub 2021 Jan 20.

Hematopoietic Stem Cell Transplantation to a Patient with Acute Myeloid Leukemia from a Sibling Donor Positive for SARS-CoV-2 by RT-PCR Test.对一名急性髓系白血病患者进行来自经逆转录聚合酶链反应（RT-PCR）检测SARS-CoV-2呈阳性的同胞供者的造血干细胞移植。

Turk J Haematol. 2022 Jun 1;39(2):150-151. doi: 10.4274/tjh.galenos.2022.2022.0086. Epub 2022 Apr 26.

COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma.异基因干细胞移植中的新冠病毒肺炎：高假阴性概率以及CRISPR和恢复期血浆的作用

Bone Marrow Transplant. 2020 Dec;55(12):2354-2356. doi: 10.1038/s41409-020-0972-8. Epub 2020 Jun 15.

Lack of transmission of SARS-CoV-2 by platelet transfusion from a COVID-19-positive donor in a hematopoietic stem cell transplantation patient.在一名造血干细胞移植患者中，新冠病毒检测呈阳性的供体所捐献的血小板未导致严重急性呼吸综合征冠状病毒2传播。

Pediatr Blood Cancer. 2021 Feb;68(2):e28658. doi: 10.1002/pbc.28658. Epub 2020 Aug 19.

Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.新型冠状病毒肺炎感染后急性白血病患者的异基因干细胞移植

Bone Marrow Transplant. 2021 Jun;56(6):1478-1481. doi: 10.1038/s41409-021-01225-w. Epub 2021 Feb 9.

The great challenge of managing recipients of hematopoietic stem cell transplantation combined with COVID-19.管理造血干细胞移植合并 COVID-19 患者的巨大挑战。

Bone Marrow Transplant. 2021 Mar;56(3):696-700. doi: 10.1038/s41409-020-01035-6. Epub 2020 Aug 25.

Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report.急性髓系白血病复发与新冠肺炎并发诊断中的实验室差异：一例报告

Int J Lab Hematol. 2021 Oct;43(5):e264-e265. doi: 10.1111/ijlh.13553. Epub 2021 Apr 21.

Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia.一名急性白血病异基因移植患者在COVID-19症状出现前检测到SARS-CoV-2病毒血症。

Bone Marrow Transplant. 2021 Mar;56(3):716-719. doi: 10.1038/s41409-020-01059-y. Epub 2020 Sep 18.

Evidence of SARS-CoV-2 Infection in Cells, Tissues, and Organs and the Risk of Transmission Through Transplantation.SARS-CoV-2 感染细胞、组织和器官的证据，以及通过移植传播的风险。

Transplantation. 2021 Jul 1;105(7):1405-1422. doi: 10.1097/TP.0000000000003744.

引用本文的文献

The impact of the donors' COVID-19 status on the outcomes of allogeneic hematopoietic stem cell transplantation: a multi-center retrospective study.供者新冠病毒病状态对异基因造血干细胞移植结局的影响：一项多中心回顾性研究

Front Microbiol. 2024 Jul 15;15:1415289. doi: 10.3389/fmicb.2024.1415289. eCollection 2024.

Utilization of SARS-COV-2 positive donors and recipients for liver transplantation in the pandemic era - An evidence-based review.大流行时代新冠病毒2型阳性供体和受体在肝移植中的应用——一项基于证据的综述

J Liver Transpl. 2022 Jul-Sep;7:100081. doi: 10.1016/j.liver.2022.100081. Epub 2022 Mar 11.

[Impact of SARS-CoV-2 infection on graft composition and early transplant outcomes following allogeneic hematopoietic stem cell transplantation].[严重急性呼吸综合征冠状病毒2感染对异基因造血干细胞移植后移植物组成及早期移植结局的影响]

Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):890-899. doi: 10.3760/cma.j.issn.0253-2727.2023.11.002.

Successful Hematopoietic Stem Cell Transplantation from a Donor Sibling Infected with SARS-CoV-2 Using Molnupiravir Prophylaxis.使用莫努匹韦进行预防，成功实现从感染了SARS-CoV-2的同胞供体进行造血干细胞移植。

Turk J Haematol. 2023 May 29;40(2):135-136. doi: 10.4274/tjh.galenos.2023.2022.0526. Epub 2023 May 15.

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety.COVID-19 大流行对非亲缘异基因造血干细胞捐献采集及其安全性的影响。

Curr Oncol. 2023 Mar 22;30(3):3549-3556. doi: 10.3390/curroncol30030270.

Allogeneic hematopoietic stem cell transplantation in the COVID-19 era.COVID-19 时代的异基因造血干细胞移植。

Front Immunol. 2023 Feb 22;14:1100468. doi: 10.3389/fimmu.2023.1100468. eCollection 2023.

The impact of COVID-19 on acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: a concise review.2019年冠状病毒病对接受异基因干细胞移植的急性髓系白血病患者的影响：简要综述

Blood Res. 2023 Mar 31;58(1):13-19. doi: 10.5045/br.2023.2022144. Epub 2023 Feb 8.

COVID-19 and HSCT (Hematopoietic stem cell transplant).COVID-19 与 HSCT（造血干细胞移植）。

Best Pract Res Clin Haematol. 2022 Sep;35(3):101399. doi: 10.1016/j.beha.2022.101399. Epub 2022 Oct 8.

COVID-19 systematic screening of asymptomatic haematopoietic stem cell donors: Less if often more.对无症状造血干细胞捐献者进行2019冠状病毒病系统筛查：少即是多。

EJHaem. 2022 Sep 15;3(4):1381-4. doi: 10.1002/jha2.556.

Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.无论是 COVID-19 还是冷冻保存，都未能阻止异基因产品输注：来自国家骨髓供者计划的报告。

Front Immunol. 2022 Sep 20;13:937900. doi: 10.3389/fimmu.2022.937900. eCollection 2022.

本文引用的文献

A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid-19 pandemic.德国骨髓捐赠者中心（DKMS）对新冠疫情期间无关供体干细胞产品冷冻保存的看法。

Am J Hematol. 2021 Mar 1;96(3):E91-E92. doi: 10.1002/ajh.26081. Epub 2021 Jan 11.

No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation.尽管在献血后出现症状的献血者血液中检测到RNA，但尚无证据表明SARS-CoV-2可通过输血传播。

Blood. 2020 Oct 15;136(16):1888-1891. doi: 10.1182/blood.2020008230.

SARS-CoV-2 viral loads and serum IgA/IgG immune responses in critically ill COVID-19 patients.危重症COVID-19患者的SARS-CoV-2病毒载量及血清IgA/IgG免疫反应

Intensive Care Med. 2020 Sep;46(9):1781-1783. doi: 10.1007/s00134-020-06157-5. Epub 2020 Jun 22.

Natural History of Asymptomatic SARS-CoV-2 Infection.无症状SARS-CoV-2感染的自然史。

N Engl J Med. 2020 Aug 27;383(9):885-886. doi: 10.1056/NEJMc2013020. Epub 2020 Jun 12.

Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.来自感染了新冠病毒的供体同胞的造血干细胞移植。

Bone Marrow Transplant. 2020 Dec;55(12):2359-2360. doi: 10.1038/s41409-020-0969-3. Epub 2020 Jun 11.

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy.COVID-19 和造血细胞移植面临的挑战；EBMT 关于造血细胞移植受者、供者和接受 CAR-T 细胞治疗患者管理的建议。

Bone Marrow Transplant. 2020 Nov;55(11):2071-2076. doi: 10.1038/s41409-020-0919-0. Epub 2020 May 13.

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia.造血干细胞移植治疗重型再生障碍性贫血：冷冻保存移植物。

Biol Blood Marrow Transplant. 2020 Jul;26(7):e161-e166. doi: 10.1016/j.bbmt.2020.04.027. Epub 2020 May 8.

SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission.SARS-CoV-2 无症状和有症状患者及输血传播风险。

Transfusion. 2020 Jun;60(6):1119-1122. doi: 10.1111/trf.15841. Epub 2020 May 27.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。

Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验